Subtopic Deep Dive
Classification of Eosinophilic Disorders
Research Guide
What is Classification of Eosinophilic Disorders?
Classification of eosinophilic disorders categorizes idiopathic, clonal, and reactive hypereosinophilic conditions using WHO criteria, clinicopathologic features, and molecular markers to guide diagnosis and therapy.
Updated classifications distinguish myeloproliferative neoplasms with eosinophilia from idiopathic hypereosinophilic syndrome (HES) and reactive forms (Valent et al., 2012, 744 citations). Consensus proposals integrate organ involvement, genetic mutations, and eosinophil counts above 1.5 × 10^9/L sustained for over 6 months (Weller and Bubley, 1994, 937 citations). Over 50 papers detail subtyping in gastrointestinal and pulmonary eosinophilic disorders.
Why It Matters
Precise classification identifies treatable clonal disorders like FIP1L1-PDGFRA-positive HES, enabling targeted tyrosine kinase inhibitors and improving survival (Weller and Bubley, 1994). It differentiates eosinophilic esophagitis from gastroesophageal reflux, directing anti-IL-5 therapies like mepolizumab over steroids (Wechsler et al., 2017, 982 citations; Furuta et al., 2007, 1664 citations). Accurate subtyping reduces misdiagnosis in EGIDs, optimizing outcomes in children and adults (Rothenberg, 2004, 908 citations).
Key Research Challenges
Distinguishing clonal from reactive
Clonal eosinophilia in myeloproliferative neoplasms overlaps with reactive forms, complicating diagnosis without genetic testing (Tefferi and Vardiman, 2007, 992 citations). Molecular markers like FIP1L1-PDGFRA are absent in many cases (Valent et al., 2012). Standardized algorithms remain inconsistent across centers.
Heterogeneous organ involvement
Eosinophilic disorders span gastrointestinal, pulmonary, and vascular systems with variable eosinophil thresholds (Talley et al., 1990, 857 citations). Clinicopathologic criteria fail to capture multisystem progression (Rosenberg et al., 2012, 942 citations). Lack of unified scoring systems hinders trials.
Evolving WHO criteria updates
Frequent revisions to WHO classifications create diagnostic uncertainty for legacy cases (Valent et al., 2012). Integration of next-generation sequencing lags in routine practice (Tefferi and Vardiman, 2007). Validation across cohorts is limited.
Essential Papers
Eosinophilic Esophagitis in Children and Adults: A Systematic Review and Consensus Recommendations for Diagnosis and Treatment
Glenn T. Furuta, Chris A. Liacouras, Margaret H. Collins et al. · 2007 · Gastroenterology · 1.7K citations
Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms
Ayalew Tefferi, J. W. Vardiman · 2007 · Leukemia · 992 citations
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
Michael E. Wechsler, Praveen Akuthota, David Jayne et al. · 2017 · New England Journal of Medicine · 982 citations
In participants with eosinophilic granulomatosis with polyangiitis, mepolizumab resulted in significantly more weeks in remission and a higher proportion of participants in remission than did place...
Eosinophils: changing perspectives in health and disease
Helene F. Rosenberg, Kimberly D. Dyer, Paul S. Foster · 2012 · Nature reviews. Immunology · 942 citations
The idiopathic hypereosinophilic syndrome
PF Weller, Glenn J. Bubley · 1994 · Blood · 937 citations
Abstract THE IDIOPATHIC hypereosinophilic syndrome (HES) is a leukoproliferative disorder, or more likely disorders, marked by a sustained overproduction of eosinophils. The distinctiveness of the...
Eosinophilic gastrointestinal disorders (EGID)
Marc E. Rothenberg · 2004 · Journal of Allergy and Clinical Immunology · 908 citations
Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues.
Nicholas J. Talley, R. G. Shorter, S.F. Phillips et al. · 1990 · Gut · 857 citations
The aim of this study was to evaluate the clinicopathological spectrum of eosinophilic gastroenteritis and identify possible difficulties in establishing the diagnosis. All patients with a diagnosi...
Reading Guide
Foundational Papers
Start with Weller and Bubley (1994, 937 citations) for core HES definition, then Tefferi and Vardiman (2007, 992 citations) for WHO myeloproliferative criteria, followed by Rothenberg (2004, 908 citations) for EGID patterns.
Recent Advances
Study Valent et al. (2012, 744 citations) consensus proposal and Wechsler et al. (2017, 982 citations) for therapy-stratified classification in EGPA.
Core Methods
Core techniques include sustained eosinophil count thresholds, PDGFRA rearrangement PCR, biopsy histology for tissue infiltration, and consensus algorithms integrating genetics with clinicopathology.
How PapersFlow Helps You Research Classification of Eosinophilic Disorders
Discover & Search
Research Agent uses searchPapers and citationGraph on 'eosinophilic disorders classification' to map 744-cited consensus by Valent et al. (2012), revealing connections to Tefferi and Vardiman (2007). exaSearch uncovers 250M+ OpenAlex papers on WHO criteria updates; findSimilarPapers expands to EGID subtyping.
Analyze & Verify
Analysis Agent applies readPaperContent to extract clinicopathologic criteria from Furuta et al. (2007), then verifyResponse with CoVe chain-of-verification flags contradictions in HES definitions (Weller and Bubley, 1994). runPythonAnalysis with pandas statistically verifies eosinophil thresholds across 10 papers; GRADE grading scores evidence strength for mepolizumab remission data (Wechsler et al., 2017).
Synthesize & Write
Synthesis Agent detects gaps in clonal vs. reactive classification via contradiction flagging on Rosenberg et al. (2012). Writing Agent uses latexEditText and latexSyncCitations to draft diagnostic algorithms, latexCompile for publication-ready tables, and exportMermaid for WHO criteria flowcharts.
Use Cases
"Extract eosinophil count thresholds from HES papers and plot distribution"
Research Agent → searchPapers('hypereosinophilic syndrome classification') → Analysis Agent → readPaperContent(Weller 1994) → runPythonAnalysis(pandas histogram of counts >1.5e9/L) → matplotlib plot of reactive vs clonal distributions.
"Draft LaTeX table comparing WHO 2008 vs 2012 eosinophil classifications"
Research Agent → citationGraph(Tefferi 2007, Valent 2012) → Synthesis Agent → gap detection → Writing Agent → latexEditText(table skeleton) → latexSyncCitations → latexCompile(PDF with criteria matrix).
"Find GitHub repos analyzing FIP1L1-PDGFRA mutations in eosinophilia"
Research Agent → searchPapers('FIP1L1-PDGFRA eosinophilic') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect(sequencing pipelines) → runPythonAnalysis(reproduce mutation stats).
Automated Workflows
Deep Research workflow conducts systematic review of 50+ papers on EGID classification, chaining searchPapers → citationGraph → GRADE grading for structured report on Rothenberg (2004). DeepScan's 7-step analysis verifies Valent et al. (2012) consensus with CoVe checkpoints and runPythonAnalysis on trial data (Wechsler et al., 2017). Theorizer generates hypotheses on molecular subtyping from Furuta et al. (2007) gene-expression profiles.
Frequently Asked Questions
What defines idiopathic hypereosinophilic syndrome?
HES requires sustained eosinophilia >1.5 × 10^9/L for 6 months with organ damage, excluding other causes (Weller and Bubley, 1994, 937 citations).
What are main classification methods?
Methods use clinicopathologic criteria, WHO algorithms, and molecular tests for clonal markers like PDGFRA fusions (Valent et al., 2012; Tefferi and Vardiman, 2007).
What are key papers on eosinophilic classification?
Valent et al. (2012, 744 citations) proposes consensus criteria; Furuta et al. (2007, 1664 citations) standardizes eosinophilic esophagitis; Weller and Bubley (1994, 937 citations) defines HES.
What open problems exist in classification?
Challenges include validating NGS for routine subtyping, standardizing multisystem scores, and updating WHO for emerging variants post-2012 (Valent et al., 2012).
Research Eosinophilic Disorders and Syndromes with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Classification of Eosinophilic Disorders with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers